| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |